3 Einträge gefunden

1. Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment:Results from the Phase 2 GMMG-DANTE Trial

   1. Leypoldt, Lisa B
   2. Gavriatopoulou, Maria
   3. Besemer, Britta
   4. Salwender, Hans
   5. Raab, Marc S
   6. Nogai, Axel
   7. Khandanpour, Cyrus

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience

   1. Ghandili, Susanne
   2. Alihodzic, Dzenefa
   3. Wiessner, Christian
   4. Bokemeyer, Carsten
   5. Weisel, Katja
   6. Leypoldt, Lisa B

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
3. Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study

   1. Schönlein, Martin
   2. Wrage, Victoria
   3. Ghandili, Susanne
   4. Mellinghoff, Sibylle C
   5. Brehm, Thomas Theo
   6. Leypoldt, Lisa B
   7. Utz, Nils

   2022 - Forschungsinformationssystem des UKE - frei zugänglich